Advertisement

Ads Placeholder
Loading...

Palatin Technologies, Inc.

PTNAMEX
Healthcare
Biotechnology
$17.72
$0.52(3.02%)
U.S. Market opens in 54h 17m

Palatin Technologies, Inc. (PTN) Stock Overview

Explore Palatin Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap460.8M
P/E Ratio-1.79
EPS (TTM)$-1.54
ROE-55.15%
Fundamental Analysis

AI Price Forecasts

1 Month$20.50
3 Months$27.29
1 Year Target$27.01

PTN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Palatin Technologies, Inc. (PTN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.16, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $27.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.79 and a market capitalization of 460.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.02%
5-Day Change
-13.94%
1-Month Change
-14.44%
3-Month Change
10.40%
6-Month Change
125.73%
Year-to-Date (YTD) Change
10.40%
1-Year Change
-33.13%
3-Year Change
-87.07%
5-Year Change
-97.97%
All-Time (Max) Change
-99.97%

Contact Information

609 495 2200
Cedar Brook Corporate Center, Cranbury, NJ, 08512

Company Facts

300 Employees
IPO DateOct 15, 1997
CountryUS
Actively Trading

Frequently Asked Questions